MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Lantern Pharma Inc. Common Stock

LTRN

#3633
Lantern Pharma Inc. Common Stock
2.8200
-2.08%
Sector:
Básica:
Profit Currency:
Rango diario
2.8200
2.8200
Rango anual
2.4500
4.2800
Cambio diario
-2.08%
Monthly Change
-13.23%
6 month change
-32.70%
Cambio anual
-32.70%
Cierres anteriores
2.8800
Open
2.8200
Bid
Ask
Low
2.8200
High
2.8200
Volumen
1
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. LTRN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Investing Investing
LTRN
2026.01.20
FDA grants orphan drug designation to Lantern Pharma’s LP-284 for sarcomas
Investing Investing
LTRN
2025.12.03
Lantern’s cancer drug LP-184 shows promise in phase 1a trial
Seeking Alpha Seeking Alpha
LTRN
2025.11.21
Lantern Pharma Inc. (LTRN) Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors Transcript
Seeking Alpha Seeking Alpha
LTRN
2025.11.15
Lantern Pharma Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:LTRN) 2025-11-15
Seeking Alpha Seeking Alpha
LTRN
2025.11.13
Lantern Pharma Inc. (LTRN) Q3 2025 Earnings Call Transcript
Investing Investing
DIS PRSO AMAT BLDP BWEN
2025.11.12
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday
Investing Investing
LTRN
2025.09.23
Lantern Pharma shareholders elect directors and approve stock option repricing
Investing Investing
LTRN
2025.09.16
Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints
Investing Investing
LTRN
2025.09.03
Lantern Pharma receives FDA feedback on pediatric brain cancer trial
The Motley Fool The Motley Fool
LTRN
2025.08.13
Lantern Pharma Narrows Loss in Q2
Investing Investing
LTRN
2025.08.06
FDA clears IND for Starlight’s brain cancer combination therapy
Investing Investing
LTRN
2025.07.31
Lantern Pharma completes Japanese enrollment in lung cancer trial

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd